Oculis Holding AG - Ordinary shares — Cash Flow (NASDAQ:OCS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities ———— — Cash from investing activities ———— — Cash from financing activities ———— — Free cash flow ———— —

News

Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect?

Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates

Vertex Pharmaceuticals (VRTX) Q2 Earnings Lag Estimates

Oculis Holding: Study Setback For Eye Drop Therapy Suggests Hold Rating (NASDAQ:OCS)

Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates

Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates

H.C. Wainwright raises Oculis stock price target to $44 on trial progress

Stifel raises Oculis stock price target to $50 on pipeline progress

Oculis Holding AG renews $100 million at-the-market offering program

Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates

Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript